The Evaluation of the Efficacy of Chemoradiotherapy(CRT) following Neo-adjuvant Treatment with Docetaxel(T)-Cisplatin(P) in Undifferentiated and Nonkeratinized Squamous Cell Carcinoma of the Nasopharynx - Phase IV Clinical Trial: A Turkish Oncology Group Study

Sadeleştirilmiş öğe sayfası
dc.contributor.authorUzel, O. E.
dc.contributor.authorOzyar, E.
dc.contributor.authorPak, Y.
dc.contributor.authorAbacioglu, U.
dc.contributor.authorAltun, M.
dc.contributor.authorKaplan, B.
dc.contributor.authorDalmaz, G.
dc.contributor.authorEsassolak, M.
dc.contributor.authorYavuz, A. A.
dc.date.accessioned2025-10-16T15:39:56Z
dc.date.issued2009
dc.description.abstract51st Annual Meeting of the American-Society-for-Radiation-Oncology, Chicago, IL, NOV 01-05, 2009
dc.identifier.doi10.1016/j.ijrobp.2009.07.894
dc.identifier.otherWOS:000270573601332
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/9933
dc.publisherELSEVIER SCIENCE INC
dc.sourceINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
dc.titleThe Evaluation of the Efficacy of Chemoradiotherapy(CRT) following Neo-adjuvant Treatment with Docetaxel(T)-Cisplatin(P) in Undifferentiated and Nonkeratinized Squamous Cell Carcinoma of the Nasopharynx - Phase IV Clinical Trial: A Turkish Oncology Group Study
dc.typeMeeting Abstract

Dosyalar

Koleksiyonlar

WOS